Full Spectrum Analytics, LLC

Full Spectrum Analytics, LLC, based in the US, provides specialized lab services that optimize laboratory operations and improve asset utilization for clients in the life sciences sector. Full Spectrum Analytics, LLC focuses on laboratory operations solutions, having been founded in 1992 in Laguna Hills, US. The company was acquired by CBRE in November 2022 for approximately USD 110 mn, enhancing CBRE's technical capabilities in Integrated Laboratory Solutions. The current CEO is Robert McLeese, who leads the company in providing critical laboratory services.

Full Spectrum Lab Services, a division of CBRE, offers a broad spectrum of integrated services aimed at enhancing laboratory operations. Their core offerings include instrument maintenance, project management, and workflow life cycle management specifically tailored for life sciences clients, including those from pharmaceuticals, biotechnology, and medical device sectors. Services address essential needs such as regulatory compliance, data integrity, and operational efficiency. The company also provides specialized consulting, lab monitoring solutions, and multi-vendor service contracts, catering to a diverse clientele across multiple sectors including oil and gas, telecommunications, and government.

Their services are marketed globally, including regions like North America, Europe, and Asia Pacific. Full Spectrum Lab Services generates revenue primarily through service contracts and maintenance agreements with clients in the life sciences and research sectors. These multi-year service agreements include ongoing support for lab instruments and equipment, periodic service visits, and on-demand repair services. The pricing plans provide flexibility, allowing clients to select service packages based on operational needs and regulatory requirements, ensuring a steady revenue stream through long-term partnerships.

Following the acquisition in November 2022, Full Spectrum Analytics, LLC aims to leverage its new affiliation with CBRE to enhance its service offerings and expand into new markets. The acquisition provides CBRE with additional technical capabilities that complement its global Integrated Laboratory Solutions. With this funding, the company plans to explore new product designs and launches, particularly in the areas of lab monitoring and compliance solutions, while also targeting expansion into additional regions across Europe and Asia by 2024.